Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()

BACKGROUND: Hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling attacks. A European treatment registry was established to review the adverse event profile and efficacy of recombinant human C1 esterase inhibitor (rhC1-INH) for HAE at...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World Allergy Organ J
Päätekijät: Valerieva, Anna, Staevska, Maria T., Grivcheva-Panovska, Vesna, Jesenak, Milos, Kőhalmi, Kinga Viktória, Hrubiskova, Katarina, Zanichelli, Andrea, Bellizzi, Luca, Relan, Anurag, Hakl, Roman, Farkas, Henriette
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: World Allergy Organization 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8093463/
https://ncbi.nlm.nih.gov/pubmed/33995818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2021.100535
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia